Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection-Reference-Cited by-同舟云学术

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection

Published:2011-01 Issue:1 Volume:53 Page:317-324
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Charlton Michael R.,Thompson Alexander,Veldt Bart J.,Watt Kym,Tillmann Hans,Poterucha John J.,Heimbach Julie K.,Goldstein David,McHutchison John

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24074/fullpdf

Reference19 articles.

1. Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histological study;Sallie;J Hepatol,1994

2. A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C;Angelico;J Hepatol,2007

3. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance;Ge;Nature,2009

4. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C;Tanaka;Nat Genet,2009

5. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy;Suppiah;Nat Genet,2009

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation;Journal of Genetic Engineering and Biotechnology;2021-11-10

2. Authors’ response to Cai et al. on their commentary on “Safe use of livers from deceased donors older than 70 years in recipients with HCV cirrhosis treated with direct-action antivirals” (Int J Surg 2021, 106096);International Journal of Surgery;2021-11

3. Comment on “Safe use of livers from deceased donors older than 70 years in recipients with HCV cirrhosis treated with direct-action antivirals. Retrospective cohort study” (Int J Surg 2021:105981);International Journal of Surgery;2021-10

4. Management of Transplant Patients Infected with HCV;Hepatitis C: Care and Treatment;2021

5. Association Between Polymorphisms in Cytokine Gene and Viral Infections in Renal and Liver Transplant Recipients: A Systematic Review;Journal of Pharmacy & Pharmaceutical Sciences;2020-05-03